A systematic review of economic evaluations of cervical cancer screening methods

Sefuthi, Thatohatsi; Nkonki, Lungiswa

doi:10.1186/s13643-022-02017-z

Systematic Reviews

Table 1 Model-based studies methodological quality appraisal

From: A systematic review of economic evaluations of cervical cancer screening methods

Quality index score for studies included in review
Model Element		Reference Index in Appendix
	3	4	5	6	7	8	9	10	11	12	13	14	16	18	19	20	22	23	24	25	26	27	29	30	32	33	34	35	36	37	38	39	40	41	42	43	44
1. Statement of decision problem/objective	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
2. Statement of scope/perspective	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	x	x	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
3. Rationale for structure	√	√	√	√	√	√	√	√	√	√	√	√	√	√	x	√	√	√	√	√	x	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
4. Structural assumptions	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	x	√	√	√	√	√	√	√	√	√	√	√	√	√	x	√	√
5. Strategies/Comparators	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
6. Model type	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
7. Time horizon	√	x	√	x	√	√	√	√	√	x	√	x	x	√	x	√	√	√	√	√	x	x	√	√	x	√	√	√	√	√	√	√	√	√	x	√	√
8. Disease states or pathways	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	x	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
9. Cycle length	+	+	√	√	+	+	√	√	+	+	x	x	x	x	x	x	√	x	x	x	x	x	x	x	+	√	√	√	√	√	√	√	√	√	x	√	√
10. Data identification	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	x	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
11. Data modelling	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	x	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
12. Baseline data	x	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	x	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
13. Treatment effects	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	x	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
14. Costs	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	x	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
15. Quality of life weights	√	√	√	√	√	√	√	√	√	√	√	x	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
16. Data incorporation	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	x	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√
17. Assessment of methodological uncertainty	x	√	√	√	x	√	√	√	√	x	x	x	√	√	x	√	√	x	√	√	√	√	√	√	√	x	√	√	√	√	√	√	√	√	√	√	√
18. Assessment of structural uncertainty	x	√	√	√	x	x	x	x	x	x	x	x	√	x	x	√	√	x	√	√	x	x	√	√	√	x	√	√	√	√	√	√	√	√	x	√	√
19. Assessment of heterogeneity uncertainty	x	x	x	x	x	x	x	x	x	x	x	x	x	x	x	√	x	x	x	x	x	x	√	√	x	x	√	√	x	x	x	x	x	x	x	x	x
20. Assessment of parameter uncertainty	x	√	√	√	√	x	√	√	√	√	√	√	√	√	x	x	√	√	+	√	x	x	√	√	√	x	√	√	√	√	√	√	√	√	√	√	√
21. Internal consistency	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	√	+	√	√	+	√	√	√	√	+	√	√	√	√	√	√	√	√	√	√	√
22. External consistency	√	√	√	√	√	√	√	√	√	√	√	+	√	√	√	√	√	+	√	√	+	√	√	√	√	+	√	√	√	√	√	√	√	√	√	√	√
Total Score by Study
√ Present	16	19	21	20	18	18	20	20	19	17	18	15	19	19	15	20	21	16	19	20	5	16	21	21	19	16	22	22	21	21	21	21	21	21	17	21	21
+ Unclear	1	2	0	1	1	1	0	0	1	2	0	2	1	0	1	0	0	2	1	0	2	0	0	0	1	2	0	0	0	0	0	0	0	0	0	0	0
x Absent	5	1	1	1	3	3	2	2	2	3	4	5	2	3	6	2	1	4	2	2	15	6	1	1	2	4	0	0	1	1	1	1	1	1	5	1	1

Back to article page

ISSN: 2046-4053

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com